Point-of-care platelet function tests: Detection of platelet inhibition induced by nonopioid analgesic drugs

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 8, 2007, Pages 775-780

  Scharbert, Gisela ^a   Gebhardt, Kristina ^a   Sow, Zacharia ^a   Duris, Monika ^a   Deusch, Engelbert ^a   Kozek Langenecker, Sibylle ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cyclooxygenase I inhibition; Platelet function; Platelets

Indexed keywords

ADRENALIN; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARACHIDONIC ACID; CITRIC ACID; CYCLOOXYGENASE 1; CYTOCHALASIN D; DICLOFENAC; NEODOLPASSE; NONSTEROID ANTIINFLAMMATORY AGENT; NORGESIC; OPIATE DERIVATIVE; PARACETAMOL; PARECOXIB; PLACEBO; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ANALYZER; ARTICLE; BLOOD CLOTTING PARAMETERS; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENZYME INHIBITION; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMPEDANCE AGGREGOMETRY; INCIDENCE; INJECTION SITE PAIN; LOW BACK PAIN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOELASTOGRAPHY;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; BLOOD PLATELETS; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; DOUBLE-BLIND METHOD; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; ISOXAZOLES; LOW BACK PAIN; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS; THROMBELASTOGRAPHY;

EID: 35848935196     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3282f10289     Document Type: Article

References (29)

1. Strumpf M, Linstedt U, Wiebalck A, Zenz M. Treatment of low back pain - significance, principles and danger. Schmerz 2001; 15:453-460.
2. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 2002; 99:13926-13931.
3. Hegi TR, Bombeli T, Seifert B, Baumann PC, Haller U, Zalunardo MP, et al. Effect of rofecoxib on platelet aggregation and blood loss in gynaecological and breast surgery compared with diclofenac. Br J Anaesth 2004; 92:523-531.
4. Munsterhjelm E, Munsterhjelm NM, Niemi TT, Ylikorkala O, Neuvonen PJ, Rosenberg PH. Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers. Anesthesiology 2005; 103:712-717.
5. Samama CM, Bastien O, Forestier F, Denninger MH, Isetta C, Juliard JM, et al. Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001 - summary statement. Can J Anaesth 2002; 49:S26-S35.
6. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003; 28:172-197.
7. Kozek-Langenecker SA, Fries D, Gütl M, Hofmann N, Innerhofer P, Kneifl W, et al. Locoregional anesthesia and coagulation inhibitors. Recommendations of the Task Force on Perioperative Coagulation of the Austrian Society for Anesthesiology and Intensive Care Medicine. Anaesthesist 2005; 54:476-484.
8. Wierod FS, Frandsen NJ, Jacobsen JD, Hartvigsen A, Olsen PR. Risk of haemorrhage from transurethral prostatectomy in acetylsalicylic acid and NSAID-treated patients. Scand J Urol Nephrol 1998; 32:120-122.
9. Koscielny J, Ziemer S, Radtke H, Schmutzler M, Pruss A, Sinha P, et al. A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10:195-204.
10. Koscielny J, von Tempelhoff GF, Ziemer S, Radtke H, Schmutzler M, Sinha P, et al. A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10:155-166.
11. Harrison P. Measuring platelet function? Hematol J 2004; 5 (Suppl 3):S164-S169.
12. Rossignol M, Abenhaim L, Bonvalot Y, Gobeille D, Shrier I. Should the gap be filled between guidelines and actual practice for management of low back pain in primary care? The Quebec experience. Spine 1996; 21:2893-2898.
13. Ang-Lee MK, Moss J, Yuan CS. Herbal medicine and perioperative care. JAMA 2001; 286:208-216.
14. Golanski J, Pietrucha T, Baj Z, Greger J, Watala CL. Molecular insight into anticoagulant-induced spontaneous activation of platelets in whole blood - various anticoagulants are not equal. Thromb Res 1996; 83:199-215.
15. Kundu S, Heilmann E, Sio R, Garcia C, Gomez R, Christie DJ. Description of an in vitro platelet function analyzer - PFA-100. Semin Thromb Hemost 1995; 21:106-112.
16. Luddington RJ. Thrombelastography/thromboelastometry [review]. Clin Lab Haematol 2005; 27:81-90.
17. Calatzis A, Wittwer M, Krueger B. A new approach to platelet function analysis in whole blood: the Multiplate Analyzer. Platelets 2004; 15:485-486.
18. Curvers J, Dielis AW, Heeremans J, van Wersch KW. Platelet function in whole-blood donors is impaired: the effects of painkillers. Transfusion 2007; 47:67-73.
19. Andersen K, Hurlen M, Arnesen H, Seljeflot I. Aspirin nonresponsiveness as measured by the PFA-100 in patients with coronary artery disease. Thromb Res 2002; 108:37-42.
20. Malinin AI, Atar D, Callahan KP, McKenzie ME, Serebruany VL. Effects of single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease. Eur J Pharmacol 2003; 462:139-143.
21. Haubelt H, Anders C, Vogt A, Hoerdt P, Seyfert UT, Hellstern P. Variables influencing Platelet Function Analyzer-100™ closure times in healthy individuals. Br J Haematol 2005; 130:759-767.
22. Lordkipanidze M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007; 28:1702-1708.
23. Seyfert UT, Haubelt H, Vogt A, Hellstern P. Variables influencing Multiplate whole-blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 2007; 18:199-206.
24. Kozek-Langenecker S. Management of massive intraoperative blood loss. Minerva Anestesiol 2007; 73:401-415.
25. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 2006; 16:31-39.
26. Craft RM, Chavez JJ, Bresee SJ, Wortham DC, Cohen E, Carroll RC. A novel modification of the thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004; 143:301-309.
27. Beatty RA. Surgery for patients with central protruded lumbar discs who have failed conservative therapy. Br J Neurosurg 1996; 10:373-377.
28. 2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents. Thromb Haemost 1989; 62:968-976.
29. Dzik WH. Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004; 3:324-330.